Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Serum Studies: Renal Function Tests

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clearing for insight: A light-sheet microscopy workflow for 3D vascular reconstruction in human first trimester placental villi and decidua.

Placenta·2026

Same author

The journey of maternal platelets through the utero-placental circulation: routes, interactions, and physiological implications.

Molecular human reproduction·2026

Same author

Associations between physical activity, sedentary behavior, body mass index and changes in placental structure and vascularization - data from the FitMum randomized controlled trial.

Placenta·2026

Same author

Exploring fetal cells in maternal blood in relation to rupture of the fetal membranes.

Placenta·2026

Same author

A comprehensive European Colorectal Cancer Cohort dataset.

Scientific data·2026

Same author

Preeclampsia 2.0: limitations and challenges of the two-stage hypothesis, and beyond.

Molecular human reproduction·2026

Search research articles

Related Experiment Video

Updated: May 21, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

First trimester serum markers to predict preeclampsia.

Berthold Huppertz¹, Rie Kawaguchi

¹Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria. berthold.huppertz@medunigraz.at

Wiener Medizinische Wochenschrift (1946)

|June 22, 2012

Summary

Researchers identified placental protein 13 and placental growth factor as early biomarkers for preeclampsia. These first-trimester markers may aid in developing future treatments for the condition.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Experiment Videos

Last Updated: May 21, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Area of Science:

Biochemistry
Obstetrics
Immunology

Background:

Preeclampsia prediction is crucial for timely intervention.
Numerous biomarkers have been investigated for preeclampsia detection.
Biomarker levels can be influenced by biological and technical factors.

Purpose of the Study:

To evaluate placental protein 13 and placental growth factor as early preeclampsia biomarkers.
To assess the predictive potential of these markers in the first trimester.

Main Methods:

Quantification of placental protein 13 in maternal blood.
Measurement of placental growth factor in maternal blood.
Evaluation of marker stability and interactions.

Main Results:

Placental protein 13 and placental growth factor show potential as early predictive markers.
First-trimester levels of these markers may indicate preeclampsia risk.
Understanding marker behavior in maternal circulation is key.

Conclusions:

Placental protein 13 and placental growth factor are promising early biomarkers for preeclampsia.
These markers could facilitate earlier diagnosis and intervention strategies.
Further research may accelerate the development of preeclampsia therapeutics.